• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Obg-like ATPase 1 (OLA1) 过表达通过调节肝细胞癌中的 P21/CDK2 促进肿瘤进展,预测不良预后。

Obg-like ATPase 1 (OLA1) overexpression predicts poor prognosis and promotes tumor progression by regulating P21/CDK2 in hepatocellular carcinoma.

机构信息

Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou 510080, China.

Organ Transplant Center, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, China.

出版信息

Aging (Albany NY). 2020 Feb 11;12(3):3025-3041. doi: 10.18632/aging.102797.

DOI:10.18632/aging.102797
PMID:32045367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7041778/
Abstract

BACKGROUND

Obg-like ATPase 1 (OLA1) has been found to have a dual role in cancers. However, the relationship between OLA1 and hepatocellular carcinoma (HCC) remains unclear.

RESULTS

High expression of OLA1 in HCC was detected in public datasets and clinical samples, and correlated with poor prognosis. Downregulation of OLA1 significantly inhibited the proliferation, migration, invasion and tumorigenicity of HCC cells. Mechanistically, GSEA showed that OLA1 might promote tumor progression by regulating the cell cycle and apoptosis. In addition, OLA1 knockdown resulted in G0/G1 phase arrest and high levels of apoptosis. OLA1 could bind with P21 and upregulate CDK2 expression to promote HCC progression.

CONCLUSIONS

Overall, these findings uncover a role for OLA1 in regulating the proliferation and apoptosis of HCC cells.

MATERIALS AND METHODS

The Cancer Genome Atlas and Gene Expression Omnibus datasets were analyzed to identify gene expression. Immunohistochemistry staining, western blot and real-time polymerase chain reaction were performed to evaluate OLA1 expression in samples. Cell count Kit-8, wound-healing, transwell and flow cytometry assays were used to analyze HCC cell progression. Subcutaneous xenotransplantation models were used to investigate the role of OLA1 in vivo. Coimmunoprecipitation was used to analyze protein interactions.

摘要

背景

Obg-like ATPase 1(OLA1)在癌症中具有双重作用。然而,OLA1 与肝细胞癌(HCC)之间的关系尚不清楚。

结果

公共数据集和临床样本中检测到 HCC 中 OLA1 的高表达,并与预后不良相关。OLA1 的下调显著抑制 HCC 细胞的增殖、迁移、侵袭和致瘤性。机制上,GSEA 表明 OLA1 可能通过调节细胞周期和细胞凋亡来促进肿瘤进展。此外,OLA1 下调导致 G0/G1 期阻滞和高水平凋亡。OLA1 可以与 P21 结合并上调 CDK2 表达以促进 HCC 进展。

结论

总的来说,这些发现揭示了 OLA1 在调节 HCC 细胞增殖和凋亡中的作用。

材料和方法

分析癌症基因组图谱和基因表达综合数据库数据集以鉴定基因表达。免疫组织化学染色、Western blot 和实时聚合酶链反应用于评估样本中 OLA1 的表达。细胞计数试剂盒-8、划痕愈合、Transwell 和流式细胞术分析用于分析 HCC 细胞进展。皮下异种移植模型用于体内研究 OLA1 的作用。免疫共沉淀用于分析蛋白质相互作用。

相似文献

1
Obg-like ATPase 1 (OLA1) overexpression predicts poor prognosis and promotes tumor progression by regulating P21/CDK2 in hepatocellular carcinoma.Obg-like ATPase 1 (OLA1) 过表达通过调节肝细胞癌中的 P21/CDK2 促进肿瘤进展,预测不良预后。
Aging (Albany NY). 2020 Feb 11;12(3):3025-3041. doi: 10.18632/aging.102797.
2
SKA3 Promotes tumor growth by regulating CDK2/P53 phosphorylation in hepatocellular carcinoma.SKA3 通过调节肝癌细胞中 CDK2/P53 的磷酸化促进肿瘤生长。
Cell Death Dis. 2019 Dec 5;10(12):929. doi: 10.1038/s41419-019-2163-3.
3
Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.GNAZ 过表达预测肝癌不良预后,并促进 G0/G1 细胞周期进程。
Gene. 2022 Jan 10;807:145964. doi: 10.1016/j.gene.2021.145964. Epub 2021 Sep 14.
4
Long non-coding RNA LINC00630 facilitates hepatocellular carcinoma progression through recruiting transcription factor E2F1 to up-regulate cyclin-dependent kinase 2 expression.长非编码 RNA LINC00630 通过招募转录因子 E2F1 上调细胞周期蛋白依赖性激酶 2 的表达促进肝细胞癌的进展。
Hum Exp Toxicol. 2021 Dec;40(12_suppl):S257-S268. doi: 10.1177/09603271211038744. Epub 2021 Aug 21.
5
Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.蛋白磷酸酶1γ(PP1γ)的过表达与肝细胞癌中细胞增殖增强及预后不良相关。
Dig Dis Sci. 2017 Jan;62(1):133-142. doi: 10.1007/s10620-016-4365-1. Epub 2016 Dec 5.
6
Exportin-T promotes tumor proliferation and invasion in hepatocellular carcinoma.Exportin-T 促进肝癌的增殖和侵袭。
Mol Carcinog. 2019 Feb;58(2):293-304. doi: 10.1002/mc.22928. Epub 2018 Nov 14.
7
TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.TRIM52 在肝癌细胞中的上调通过泛素化 PPM1A 促进增殖、迁移和侵袭。
J Exp Clin Cancer Res. 2018 Jun 13;37(1):116. doi: 10.1186/s13046-018-0780-9.
8
OLA1 contributes to epithelial-mesenchymal transition in lung cancer by modulating the GSK3β/snail/E-cadherin signaling.OLA1 通过调节 GSK3β/蜗牛/E-钙黏蛋白信号通路促进肺癌上皮-间质转化。
Oncotarget. 2016 Mar 1;7(9):10402-13. doi: 10.18632/oncotarget.7224.
9
Combined OLA1 and CLEC3B Gene Is a Prognostic Signature for Hepatocellular Carcinoma and Impact Tumor Progression.联合 OLA1 和 CLEC3B 基因是肝细胞癌的预后标志物,并影响肿瘤进展。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241241935. doi: 10.1177/15330338241241935.
10
HJURP promotes hepatocellular carcinoma proliferation by destabilizing p21 via the MAPK/ERK1/2 and AKT/GSK3β signaling pathways.HJURP 通过 MAPK/ERK1/2 和 AKT/GSK3β 信号通路促进肝细胞癌增殖,导致 p21 不稳定。
J Exp Clin Cancer Res. 2018 Aug 15;37(1):193. doi: 10.1186/s13046-018-0866-4.

引用本文的文献

1
Identification of positive cofactor 4 as a diagnostic and prognostic biomarker associated with immune infiltration in hepatocellular carcinoma.鉴定正辅因子4作为与肝细胞癌免疫浸润相关的诊断和预后生物标志物。
ILIVER. 2023 Sep 15;2(4):188-201. doi: 10.1016/j.iliver.2023.08.007. eCollection 2023 Dec.
2
Bioengineered platelet nanoplatform enables renal-targeted dexamethasone delivery for chronic nephritis therapy with dual anti-inflammatory/anti-fibrotic effects and minimized systemic toxicity.生物工程血小板纳米平台实现肾靶向地塞米松递送,用于慢性肾炎治疗,具有双重抗炎/抗纤维化作用,并将全身毒性降至最低。
Bioact Mater. 2025 Jun 7;52:213-227. doi: 10.1016/j.bioactmat.2025.06.002. eCollection 2025 Oct.
3

本文引用的文献

1
The Multifaceted p21 (Cip1/Waf1/) in Cell Differentiation, Migration and Cancer Therapy.细胞分化、迁移及癌症治疗中的多面性p21(Cip1/Waf1/)
Cancers (Basel). 2019 Aug 21;11(9):1220. doi: 10.3390/cancers11091220.
2
Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west.肝细胞癌合并门静脉癌栓患者的管理:东西比较。
Lancet Gastroenterol Hepatol. 2019 Sep;4(9):721-730. doi: 10.1016/S2468-1253(19)30178-5.
3
Hepatocellular Carcinoma.肝细胞癌
Identification and development of Tetra-ARMS PCR-based screening test for a genetic variant of OLA1 (Tyr254Cys) in the human failing heart.
鉴定和开发基于 Tetra-ARMS PCR 的筛选试验,用于检测人类衰竭心脏中 OLA1(Tyr254Cys)遗传变异。
PLoS One. 2024 Jun 18;19(6):e0293105. doi: 10.1371/journal.pone.0293105. eCollection 2024.
4
Obg-like ATPase 1 exacerbated gemcitabine drug resistance of pancreatic cancer.Obg样ATP酶1加剧了胰腺癌对吉西他滨的耐药性。
iScience. 2024 May 21;27(6):110027. doi: 10.1016/j.isci.2024.110027. eCollection 2024 Jun 21.
5
Combined OLA1 and CLEC3B Gene Is a Prognostic Signature for Hepatocellular Carcinoma and Impact Tumor Progression.联合 OLA1 和 CLEC3B 基因是肝细胞癌的预后标志物,并影响肿瘤进展。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241241935. doi: 10.1177/15330338241241935.
6
Whole-Exome Sequencing (WES) Reveals Novel Sex-Specific Gene Variants in Non-Alcoholic Steatohepatitis (MASH).全外显子组测序(WES)揭示了非酒精性脂肪性肝炎(MASH)中性别特异性的新基因变异。
Genes (Basel). 2024 Mar 13;15(3):357. doi: 10.3390/genes15030357.
7
OLA1 Phosphorylation: A Distress Signal from Damaged Endothelial Mitochondria?OLA1磷酸化:来自受损内皮线粒体的应激信号?
Am J Respir Cell Mol Biol. 2023 Apr;68(4):347-348. doi: 10.1165/rcmb.2022-0450ED.
8
OLA1 Phosphorylation Governs the Mitochondrial Bioenergetic Function of Pulmonary Vascular Cells.OLA1 磷酸化调控肺血管细胞的线粒体生物能功能。
Am J Respir Cell Mol Biol. 2023 Apr;68(4):395-405. doi: 10.1165/rcmb.2022-0186OC.
9
Genetic Analysis of Platelet-Related Genes in Hepatocellular Carcinoma Reveals a Novel Prognostic Signature and Determines PRKCD as the Potential Molecular Bridge.肝细胞癌中血小板相关基因的遗传分析揭示了一种新的预后特征,并确定PRKCD为潜在的分子桥梁。
Biol Proced Online. 2022 Dec 3;24(1):22. doi: 10.1186/s12575-022-00185-9.
10
Identification by genetic algorithm optimized back propagation artificial neural network and validation of a four-gene signature for diagnosis and prognosis of pancreatic cancer.通过遗传算法优化的反向传播人工神经网络进行识别以及验证用于胰腺癌诊断和预后的四基因特征
Heliyon. 2022 Nov 9;8(11):e11321. doi: 10.1016/j.heliyon.2022.e11321. eCollection 2022 Nov.
N Engl J Med. 2019 Jul 4;381(1):e2. doi: 10.1056/NEJMc1906565.
4
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma.多组学发现肝细胞癌中胚系衍生的新抗原。
Genome Med. 2019 Apr 30;11(1):28. doi: 10.1186/s13073-019-0636-8.
5
Hepatocellular Carcinoma.肝细胞癌
N Engl J Med. 2019 Apr 11;380(15):1450-1462. doi: 10.1056/NEJMra1713263.
6
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma.蛋白质组学鉴定早期肝细胞癌的新治疗靶点。
Nature. 2019 Mar;567(7747):257-261. doi: 10.1038/s41586-019-0987-8. Epub 2019 Feb 27.
7
RACK1 regulates centriole duplication by controlling localization of BRCA1 to the centrosome in mammary tissue-derived cells.RACK1 通过控制 BRCA1 在乳腺组织来源细胞中的中心体定位来调节中心体复制。
Oncogene. 2019 Apr;38(16):3077-3092. doi: 10.1038/s41388-018-0647-8. Epub 2019 Jan 7.
8
Goals and targets for personalized therapy for HCC.肝癌个体化治疗的目标和靶点。
Hepatol Int. 2019 Mar;13(2):125-137. doi: 10.1007/s12072-018-9919-1. Epub 2019 Jan 1.
9
Uridine-cytidine kinase 2 upregulation predicts poor prognosis of hepatocellular carcinoma and is associated with cancer aggressiveness.尿苷-胞苷激酶 2 的上调预示着肝细胞癌的预后不良,并且与癌症的侵袭性有关。
Mol Carcinog. 2019 Apr;58(4):603-615. doi: 10.1002/mc.22954. Epub 2019 Jan 22.
10
An insight into the emerging role of cyclin-dependent kinase inhibitors as potential therapeutic agents for the treatment of advanced cancers.深入了解细胞周期蛋白依赖性激酶抑制剂作为治疗晚期癌症的潜在治疗药物的新兴作用。
Biomed Pharmacother. 2018 Nov;107:1326-1341. doi: 10.1016/j.biopha.2018.08.116. Epub 2018 Aug 29.